Transcripts
Cognition Therapeutics (CGTX) earnings call transcripts
Earnings call transcripts for Cognition Therapeutics Inc., with a summary, the guidance given, and what analysts pressed on.
- Q4 2025 earnings call
Management reframed development around DLB psychosis as a potentially faster registration path, while keeping Alzheimer’s development contingent on START results.
Mar 26, 2026Positive0.55